ivabradine hydrochloride
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
17 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
American Health Packaging
Amgen Inc
Bionpharma Inc.
Camber Pharmaceuticals, Inc.
Golden State Medical Supply, Inc.
Hetero Drugs Limited
Ingenus Pharmaceuticals, LLC
Maithri Laboratories Private Limited
Novadoz Pharmaceuticals LLC
Optimus Drugs Private Limited
ORIL Industrie
Patheon Manufacturing Services LLC
Urquima, S.A.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Ivabradine
- •Corlanor
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Ivabradine Hydrochloride Tablet
03/24/2026Chemical Identity
CAS148849-67-6
PubChem CID3045381
DTXSIDDTXSID2046913
FormulaC27H37ClN2O5
Mol. Weight505 g/mol
SMILESCN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl
Data Sources
30453812026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ivabradine hydrochloride/cids/JSON
Archive: data/sources/pubchem_name/ivabradine hydrochloride.json
CAS 148849-67-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 148849-67-62026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json